Statement 2 March 2022

Pharmaceutical industry response to the crisis in Ukraine

By IFPMA
Share

2 March 2022 – As the situation in Ukraine continues to cause unimaginable suffering, our thoughts are with the people in Ukraine. Overcoming the challenges that this unprecedented humanitarian crisis poses for patients is our main concern.  We are supporting the efforts of our sister regional organization – EFPIA – to ensure vital medicines reach the people who need them most and the health needs of the many thousands of people already displaced by the crisis are met.

Pharmaceutical industry response to the war in Ukraine can be found here: 

https://www.efpia.eu/news-events/the-efpia-view/efpia-news/pharmaceutical-industry-response-to-the-war-in-ukraine   (updated regularly)

About IFPMA

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.

Learn more

Media Contact

Abigail Jones
Top